Shares of ImmunoGen, Inc. (NASDAQ:IMGN – Get Free Report) have been assigned an average rating of “Hold” from the twelve research firms that are currently covering the stock, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average […]
StockNews.com started coverage on shares of ImmunoGen (NASDAQ:IMGN – Free Report) in a research report released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. IMGN has been the topic of several other research reports. Jefferies Financial Group reaffirmed a hold rating and issued a $31.00 target price on shares […]
Algert Global LLC purchased a new stake in ImmunoGen, Inc. (NASDAQ:IMGN – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 180,317 shares of the biotechnology company’s stock, valued at approximately $2,862,000. Algert Global LLC owned approximately 0.07% of ImmunoGen at the […]
ImmunoGen (NASDAQ:IMGN) Receives New Coverage from Analysts at StockNews.com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Victory Capital Management Inc. grew its position in shares of ImmunoGen, Inc. (NASDAQ:IMGN – Free Report) by 16.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 140,846 shares of the biotechnology company’s stock after purchasing an additional 19,419 shares […]